This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2022 Feb 10;386(6):568-581.

doi: 10.1056/NEJMra2102568.

Marginal-Zone Lymphomas

Davide Rossi¹, Francesco Bertoni¹, Emanuele Zucca¹

Affiliations

Affiliation

¹ From the International Extranodal Lymphoma Study Group, Bellinzona; the Institute of Oncology Research, Bellinzona; the Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona; and the Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano - all in Switzerland.

PMID: 35139275
DOI: 10.1056/NEJMra2102568

Review

Marginal-Zone Lymphomas

Davide Rossi et al. N Engl J Med. 2022.

. 2022 Feb 10;386(6):568-581.

doi: 10.1056/NEJMra2102568.

Authors

Davide Rossi¹, Francesco Bertoni¹, Emanuele Zucca¹

Affiliation

¹ From the International Extranodal Lymphoma Study Group, Bellinzona; the Institute of Oncology Research, Bellinzona; the Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona; and the Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano - all in Switzerland.

PMID: 35139275
DOI: 10.1056/NEJMra2102568

No abstract available

PubMed Disclaimer

Comment in

Marginal-Zone Lymphomas.
Matuchansky C. Matuchansky C. N Engl J Med. 2022 May 19;386(20):1962. doi: 10.1056/NEJMc2203319. N Engl J Med. 2022. PMID: 35584170 No abstract available.
Marginal-Zone Lymphomas.
Henry B, Buffet P, Bates I. Henry B, et al. N Engl J Med. 2022 May 19;386(20):1962. doi: 10.1056/NEJMc2203319. N Engl J Med. 2022. PMID: 35584171 No abstract available.

Similar articles

Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM, Castillo JJ. Juárez-Salcedo LM, et al. Hematol Oncol Clin North Am. 2019 Aug;33(4):639-656. doi: 10.1016/j.hoc.2019.03.004. Epub 2019 Apr 30. Hematol Oncol Clin North Am. 2019. PMID: 31229160 Review.
Non-MALT marginal zone lymphomas.
Thieblemont C. Thieblemont C. Ann Oncol. 2008 Jun;19 Suppl 4:iv70-3. doi: 10.1093/annonc/mdn202. Ann Oncol. 2008. PMID: 18519410 Review. No abstract available.
Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Zucca E, Dreyling M; ESMO Guidelines Working Group. Zucca E, et al. Ann Oncol. 2008 May;19 Suppl 2:ii70-1. doi: 10.1093/annonc/mdn094. Ann Oncol. 2008. PMID: 18456776 No abstract available.
Transformation of marginal zone lymphoma (and association with other lymphomas).
Casulo C, Friedberg J. Casulo C, et al. Best Pract Res Clin Haematol. 2017 Mar-Jun;30(1-2):131-138. doi: 10.1016/j.beha.2016.08.029. Epub 2016 Nov 4. Best Pract Res Clin Haematol. 2017. PMID: 28288708 Review.
[Gastrointestinal lymphoma: etiology, pathogenesis and therapy].
Fischbach W. Fischbach W. Internist (Berl). 2000 Sep;41(9):831-40. doi: 10.1007/s001080050635. Internist (Berl). 2000. PMID: 11006870 Review. German. No abstract available.

See all similar articles

Cited by

Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.
Grover NS, Annunzio K, Watkins M, Torka P, Karmali R, Anampa-Guzmán A, Oh TS, Reves H, Tavakkoli M, Hansinger E, Christian B, Thomas C, Barta SK, Geethakumari PR, Bartlett NL, Shouse G, Olszewski AJ, Epperla N. Grover NS, et al. Blood Cancer J. 2024 Oct 18;14(1):182. doi: 10.1038/s41408-024-01162-z. Blood Cancer J. 2024. PMID: 39424808 Free PMC article.
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
Hopper MA, Dropik AR, Walker JS, Novak JP, Laverty MS, Manske MK, Wu X, Wenzl K, Krull JE, Sarangi V, Maurer MJ, Yang ZZ, Del Busso MD, Habermann TM, Link BK, Rimsza LM, Witzig TE, Ansell SM, Cerhan JR, Jevremovic D, Novak AJ. Hopper MA, et al. Blood Cancer J. 2024 Oct 9;14(1):172. doi: 10.1038/s41408-024-01145-0. Blood Cancer J. 2024. PMID: 39384745 Free PMC article.
Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma.
Wang H, Zhang Y, Li Z, Bai O. Wang H, et al. Front Immunol. 2024 Sep 23;15:1466859. doi: 10.3389/fimmu.2024.1466859. eCollection 2024. Front Immunol. 2024. PMID: 39376572 Free PMC article.
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma.
Packness E, Davidsson OB, Rostgaard K, Andersen MA, Rotbain EC, Niemann CU, Brieghel C, Hjalgrim H. Packness E, et al. Br J Cancer. 2024 Oct;131(7):1186-1194. doi: 10.1038/s41416-024-02816-2. Epub 2024 Aug 22. Br J Cancer. 2024. PMID: 39174738 Free PMC article.
Long-term survival outcomes of 'watch and wait' in patients with bronchus-associated lymphoid tissue lymphoma: a multicenter real-world data analysis in Korea.
Kwak K, Yoo KH, Choi YS, Park Y, Kim BS, Yoon SE, Kim WS, Kang KW, Kim SJ. Kwak K, et al. Ann Hematol. 2024 Oct;103(10):4193-4202. doi: 10.1007/s00277-024-05902-w. Epub 2024 Jul 29. Ann Hematol. 2024. PMID: 39075295

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.